Market Overview:
The global drug discovery software market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for drugs and rising number of approvals for new drugs by regulatory authorities across the globe. In addition, growing investments by pharmaceutical companies in drug discovery research and development are also contributing to the growth of this market. Based on type, the global drug discovery software market can be segmented into cloud-based and web-based software. The cloud-based segment is expected to grow at a higher CAGR than the web-based segment during the forecast period from 2018 to 2030. This can be attributed to factors such as lower costs associated with deployment and maintenance of cloud-based software, easy upgradation, and scalability offered by these solutions. Based on application, the global drug discovery software market can be divided into CROs & universities, companies, testing labs & other end users segments. The CROs & universities segment is projected to account for a larger share of this market in 2018 than that accounted by other end users segments such as testing labs & others segments combined together owing high adoption rates for these solutions among academic institutions as well as contract research organizations (CROs).
Product Definition:
Drug discovery software is used to identify potential drug candidates. It can be used to screen large databases of compounds for those that may have the desired effect on a particular target. The software can also be used to model the interactions between a drug and its target, which can help in predicting how the drug will behave in humans. This information is important in helping to speed up the process of drug discovery and development.
Cloud Based:
Cloud-based solutions are software-as-a-service (SaaS) applications that store data on a remote server rather than the user's computer. Cloud computing is an umbrella term for the collection of technologies and tools that make up digital infrastructure. It includes services like storage, networking, and application development as well as virtualization technology.
Web Based:
The global web-based and it's usage in drug discovery software market size was valued at USD 6.5 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period.
Application Insights:
The companies segment held the largest market share in 2017. Companies are majorly investing in R&D activities to develop new drugs and therapies. The companies invest heavily on research projects related to drug discovery and development, which involves the use of various software applications for data management & analysis. For instance, PhosphoSitePlus by Merck Millipore is used for identifying protein-protein interactions that occur between two or more proteins within a cell membrane. This helps researchers analyze complex biological datasets with ease while discovering novel targets for drug development.
The CROs segment is expected to grow at a lucrative rate over the forecast period owing to increasing collaborations & partnerships among organizations, government agencies & funding bodies, and private institutions/research groups worldwide regarding disease diagnosis through biobanks or clinical trials studies involving human participants (iTRAQ).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to increasing R&D investments by companies and universities. Asia Pacific is anticipated to witness lucrative growth over the next eight years due to rising awareness about drug discovery software applications, growing healthcare IT infrastructure, and increasing government funding for research projects in this region. Moreover, a large number of potential users reside within this region as many Asian countries are emerging as hubs for outsourcing services including technical support & maintenance jobs and data processing & analysis jobs related to these softwares.
Growth Factors:
- Increasing demand for novel drugs to treat various diseases
- Rising prevalence of chronic diseases and cancer
- Growing number of drug discovery collaborations between pharmaceutical companies and academic institutions
- Advances in informatics and computational biology that are aiding in the identification of new drug targets
- Increased funding for drug discovery research by government agencies and private foundations
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Discovery Software Market Research Report
By Type
Cloud Based, Web Based
By Application
CROs and Universities, Companies, Testing Labs
By Companies
Epocrates, MicroTracker, DrugPatentWatch, PEPID PDC, AtomWise, InSilicoTrials, Thermo Scientific, AutoDock, CCD Vault, Compound Assist, DrugDev Spark, DSG Drug Safety
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
193
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Drug Discovery Software Market Report Segments:
The global Drug Discovery Software market is segmented on the basis of:
Types
Cloud Based, Web Based
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
CROs and Universities, Companies, Testing Labs
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Epocrates
- MicroTracker
- DrugPatentWatch
- PEPID PDC
- AtomWise
- InSilicoTrials
- Thermo Scientific
- AutoDock
- CCD Vault
- Compound Assist
- DrugDev Spark
- DSG Drug Safety
Highlights of The Drug Discovery Software Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cloud Based
- Web Based
- By Application:
- CROs and Universities
- Companies
- Testing Labs
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Discovery Software Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug discovery software is a computer program that helps researchers identify new drugs and develop better treatments for diseases. The software can help scientists find new targets for drug development, screen potential drug candidates, and analyze data from preclinical studies.
Some of the key players operating in the drug discovery software market are Epocrates, MicroTracker, DrugPatentWatch, PEPID PDC, AtomWise, InSilicoTrials, Thermo Scientific, AutoDock, CCD Vault, Compound Assist, DrugDev Spark, DSG Drug Safety.
The drug discovery software market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug Discovery Software Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drug Discovery Software Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drug Discovery Software Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drug Discovery Software Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drug Discovery Software Market Size & Forecast, 2018-2028
4.5.1 Drug Discovery Software Market Size and Y-o-Y Growth
4.5.2 Drug Discovery Software Market Absolute $ Opportunity
Chapter 5 Global Drug Discovery Software Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Drug Discovery Software Market Size Forecast by Type
5.2.1 Cloud Based
5.2.2 Web Based
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Drug Discovery Software Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Drug Discovery Software Market Size Forecast by Applications
6.2.1 CROs and Universities
6.2.2 Companies
6.2.3 Testing Labs
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drug Discovery Software Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drug Discovery Software Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Drug Discovery Software Analysis and Forecast
9.1 Introduction
9.2 North America Drug Discovery Software Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Drug Discovery Software Market Size Forecast by Type
9.6.1 Cloud Based
9.6.2 Web Based
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Drug Discovery Software Market Size Forecast by Applications
9.10.1 CROs and Universities
9.10.2 Companies
9.10.3 Testing Labs
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Drug Discovery Software Analysis and Forecast
10.1 Introduction
10.2 Europe Drug Discovery Software Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Drug Discovery Software Market Size Forecast by Type
10.6.1 Cloud Based
10.6.2 Web Based
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Drug Discovery Software Market Size Forecast by Applications
10.10.1 CROs and Universities
10.10.2 Companies
10.10.3 Testing Labs
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Drug Discovery Software Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Drug Discovery Software Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Drug Discovery Software Market Size Forecast by Type
11.6.1 Cloud Based
11.6.2 Web Based
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Drug Discovery Software Market Size Forecast by Applications
11.10.1 CROs and Universities
11.10.2 Companies
11.10.3 Testing Labs
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Drug Discovery Software Analysis and Forecast
12.1 Introduction
12.2 Latin America Drug Discovery Software Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Drug Discovery Software Market Size Forecast by Type
12.6.1 Cloud Based
12.6.2 Web Based
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Drug Discovery Software Market Size Forecast by Applications
12.10.1 CROs and Universities
12.10.2 Companies
12.10.3 Testing Labs
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Drug Discovery Software Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Drug Discovery Software Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Drug Discovery Software Market Size Forecast by Type
13.6.1 Cloud Based
13.6.2 Web Based
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Drug Discovery Software Market Size Forecast by Applications
13.10.1 CROs and Universities
13.10.2 Companies
13.10.3 Testing Labs
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drug Discovery Software Market: Competitive Dashboard
14.2 Global Drug Discovery Software Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Epocrates
14.3.2 MicroTracker
14.3.3 DrugPatentWatch
14.3.4 PEPID PDC
14.3.5 AtomWise
14.3.6 InSilicoTrials
14.3.7 Thermo Scientific
14.3.8 AutoDock
14.3.9 CCD Vault
14.3.10 Compound Assist
14.3.11 DrugDev Spark
14.3.12 DSG Drug Safety
